Boston scientific corporation (U.S.) and Medtronic (U.S.) are Leading Players in the Gastrointestinal Products Market
The Gastroenterology Market is projected to reach USD 19.7 billion by 2029 from USD 14.7 billion in 2024, at a CAGR of 6.1 % from 2024 to 2029. The market is growing significantly due to the prevalence of Gastrointestinal diseases, increasing geriatric populations, and funding from government agencies for research and drug development.
The Gastrointestinal Products Marketis highly consolidated and is dominated by key players. The major players operating in this market are Boston scientific corporation (U.S.), Olympus Corporation (Japan), Medtronic (U.S.), Stryker (U.S), and Fujiflim Corporation (Japan) among others.
To know about the assumptions considered for the study download the pdf brochure
BOSTON SCIENTIFIC ( U.S)
Boston Scientific is a leading player in the gastroenterology market, offering a diverse range of innovative products designed to diagnose and treat gastrointestinal disorders. Their portfolio includes advanced endoscopic devices like the SpyGlass DS Direct Visualization System, which enhances the diagnosis and treatment of bile duct and pancreatic diseases. They also offer the EXALT Model D Single-Use Duodenoscope, which minimizes infection risks associated with reusable devices during ERCP procedures. Therapeutic solutions such as the AXIOS Stent and Electrocautery Enhanced Delivery System, along with CRE Balloon Dilatation Catheters, address various GI conditions, improving procedural efficiency and patient outcomes. Through continuous innovation, strategic acquisitions, and a strong global distribution network, Boston Scientific significantly contributes to advancing gastroenterological care and improving patient quality of life worldwide.
MEDTRONIC( U.S)
Medtronic is a significant force in the gastroenterology market, providing an array of cutting-edge products designed to diagnose and treat gastrointestinal conditions. Notable innovations include the GI Genius Intelligent Endoscopy Module, launched in March 2021, which uses artificial intelligence to enhance the detection of colorectal polyps during colonoscopies. This technology assists in real-time decision-making, improving diagnostic accuracy and patient outcomes. Medtronic also offers the PillCam capsule endoscopy, a minimally invasive diagnostic tool that captures images of the digestive tract, providing a comprehensive view that aids in the detection of diseases such as Crohn's disease and obscure gastrointestinal bleeding. Through continuous investment in research and development, Medtronic has maintained a robust pipeline of gastroenterology products, focusing on improving patient care and procedural efficiency. Their strategic approach includes integrating advanced technologies and expanding their global reach, thereby reinforcing their leadership in the gastroenterology sector.
OLYMPUS CORPORATION (JAPAN)
Olympus Corporation is a leading provider in the gastroenterology market, known for its innovative endoscopic technologies and comprehensive solutions for diagnosing and treating gastrointestinal diseases. Their flagship product, the EVIS X1 endoscopy system, incorporates advanced imaging technologies such as Texture and Color Enhancement Imaging (TXI), Red Dichromatic Imaging (RDI), and Narrow Band Imaging (NBI), enhancing visualization and aiding in the early detection of GI conditions. Olympus also offers a wide range of endoscopes and therapeutic devices, including the DualKnife J, an endoscopic submucosal dissection (ESD) tool designed for precise tissue resection. Additionally, their Endocuff Vision device improves mucosal exposure during colonoscopy, increasing adenoma detection rates. Through continuous innovation and a strong commitment to improving patient outcomes, Olympus maintains its leadership in the gastroenterology sector, providing healthcare professionals with state-of-the-art tools to advance diagnostic and therapeutic procedures.
Related Reports:
Gastroenterology/Gastrointestinal Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Forecast to 2029
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
